Downregulation of TSPX has been linked to aberrant DNA hypermethylation, as treatment with the demethylating agent 5-aza-2′deoxycytidine restores its expression in NSCLC and glioma cell lines [15,18]. This evidence concerns the gene TSPYL2 and non-small cell lung carcinoma.